Annual Report 2021

Since the pandemic started to affect the Medistim business in second quarter of 2020, the effect has become gradually smaller, and in the second quarter of 2021, there was a strong rebound in procedures performed and hence in the sales revenues.

This rebound has continued throughout 2021, and Medistim has experienced strong growth in revenues due to the increase in number of CABG procedures performed. The sales growth was 17.6 % in NOK and operating profit (EBIT) growth was 21.8% in NOK. The Medistim Group’s sales for the full year 2021 ended at NOK 427.3 million (NOK 363.1 million). Currency neutral sales increased 24.6%.

Read the full report here:
Annual Report 2021
Medistim ASA-2021-12-31-en.zip

Name of cookie	Time of storage	Provider	Description
_ga	2 years	medistim.com	This cookie registers your unique ID upon your visit, to generate statistical data on how you use our website.
_gat	1 day	medistim.com	This cookie is used by Google Analytics to throttle the request rate.
_gid	1 day	medistim.com	This cookie registers a unique ID that is used to generate statistical data on how you use our website.
p.gif	Session	typekit.net	This cookie keeps track of special fonts used on the site for internal analysis. This cookie does not register any visitor data.

Name of cookie	Time of storage	Provider	Description
ads/ga.audiences	Session	google.com	This cookie is used by Google Adwords to re-engage visitors that are likely to convert to customers based on the visitor's online behaviour across websites
r/collect	Session	doubleclick.net	This cookie is used to send data to Google Analytics about the visitor's device and behavior. The cookie tracks visitors across devices and marketing channels.